Flow chart of study design. Rx = treatment; AZT = zidovdine and lamivudine; TDF = tenofovir and emtricitabine; ABC = abacavir and lamivudine.

Shape of the concentration-prophylaxis profile.

Sulav Duwal (152805)
Laura Dickinson (5394566)
Saye Khoo (575924)
Max von Kleist (152808)

February 2019

Colored lines depict the concentration-prophylaxis profile for an average drug class-specific slope ...

Ordinary least squares regression of the natural log of total per patient costs for the first year on ART against study site and patient-specific characteristicsa.

Callie A. Scott (324456)
Hari Iyer (69841)
Deophine Lembela Bwalya (428682)
Kelly McCoy (428683)
Gesine Meyer-Rath (144675)
Crispin Moyo (428684)
Carolyn Bolton-Moore (428685)
Bruce Larson (325522)
Sydney Rosen (213204)

June 2013

3TC: lamivudine; ABC: abacavir; ART: antiretroviral therapy; AZT: zidovudine; CI: confidence inte...

Flow diagram of patients enrolled in the TrEAT TD clinical trial and paired samples that were included in the present analysis.

Tahaniyat Lalani (328713)
Michele D. Tisdale (5704316)
Jie Liu (15128)
Indrani Mitra (663794)
Cliff Philip (5704319)
Elizabeth Odundo (5704322)
Faviola Reyes (5704325)
Mark P. Simons (846690)
Jamie A. Fraser (5704328)
Emma Hutley (5704331)
Patrick Connor (5704334)
Brett E. Swierczewski (370939)
Eric Houpt (75426)
David R. Tribble (371883)
Mark S. Riddle (371884)

August 2018

Flow diagram of patients enrolled in the TrEAT TD clinical trial and paired samples that were includ...

Flow chart of participants through the clinical trial.

Huijuan Kou (276581)
Xiaoli Du (276582)
Yanling Li (269030)
Jing Xie (180526)
Zhifeng Qiu (269028)
Min Ye (171404)
Qiang Fu (129583)
Yang Han (269027)
Zhu Zhu (142480)
Taisheng Li (269024)

January 2013

ART: antiretroviral therapy; AZT: zidovudine; NVP: nevirapine; 3TC: lamivudine; D4T: stavudine; C...

CONSORT Diagram.

Kirsten Salado-Rasmussen (712677)
Zahra P. Theilgaard (712678)
Mercy G. Chiduo (712679)
Ib C. Bygbjerg (151419)
Jan Gerstoft (67009)
Margrethe Lüneborg-Nielsen (712680)
Martha Lemnge (103946)
Terese L. Katzenstein (417663)

March 2015

The flow chart indicates the number of women included from the ComTru study. The women were alloc...

Flow diagram of patient selection.

Yohei Hamada (434087)
Takeshi Nishijima (212471)
Hirokazu Komatsu (209445)
Katsuji Teruya (212494)
Hiroyuki Gatanaga (205448)
Yoshimi Kikuchi (212497)
Shinichi Oka (205454)

July 2013

ART, antiretroviral treatment; ATV, atazanavir; PIs, protease inhibitors; LPV/r, lopinavir/ritona...

Included studies and treatment groups.

Frederick J. Lee (564804)
Janaki Amin (157661)
Andrew Carr (157672)

May 2014

ABC, abacavir; AZT, zidovudine; APV, amprenavir; AZV, atazanavir; d4T, stavudine; ddI, didanosine...

Study flowchart.

Janneke H. van Dijk (277226)
Catherine G. Sutcliffe (185370)
Francis Hamangaba (277227)
Christopher Bositis (277228)
Douglas C. Watson (277229)
William J. Moss (185392)

January 2013

ART: antiretroviral treatment; ATT: anti-tuberculous treatment; EFV: efavirenz; FU: follow-up; LT...

Flow diagram of patient selection.

Takeshi Nishijima (212471)
Yohei Hamada (434087)
Koji Watanabe (205444)
Hirokazu Komatsu (209445)
Ei Kinai (212480)
Kunihisa Tsukada (212489)
Katsuji Teruya (212494)
Hiroyuki Gatanaga (205448)
Yoshimi Kikuchi (212497)
Shinichi Oka (205454)

October 2013

ART, antiretroviral therapy; ATV, atazanavir; DRV/r, ritonavir-boosted darunavir; ATV/r, ritonavi...

Drug-combination counts for therapies in EuResistTCE and HIVdbTCE.

Alejandro Pironti (738435)
Nico Pfeifer (45036)
Hauke Walter (367450)
Björn-Erik O. Jensen (3916373)
Maurizio Zazzi (146810)
Perpétua Gomes (257023)
Rolf Kaiser (238438)
Thomas Lengauer (14699)

April 2017

The frequencies of the 20 most-frequent drug combinations in EuResistTCE (a) and HIVdbTCE (b) dat...

Flowchart of the selection of study participants.

In Ah Choi (6185000)
Jeong Seok Lee (2236030)
Yeong Wook Song (219636)
Eun Young Lee (219648)

January 2019

*Methotrexate, sulfasalazine, hydroxychloroquine, leflunomide, tacrolimus, bucillamine, mizoribine, ...

Study Characteristics.

Nathan Ford (59436)
Zara Shubber (279389)
Andrew Hill (95939)
Marco Vitoria (183846)
Meg Doherty (482820)
Edward J. Mills (34548)
Andy Gray (482821)

November 2013

3TC, lamivudine; ATV/r, ritonavir-boosted atazanavir; AZT, zidovudine; ABC, abacavir; d4T, stavud...

Clinical details of HIV-1 infected patients used in this study.

Edwin Leeansyah (366399)
Jingling Zhou (332197)
Geza Paukovics (287229)
Sharon R. Lewin (130160)
Suzanne M. Crowe (220340)
Anthony Jaworowski (220337)

February 2013

13TC: lamivudine, ABC: abacavir, ATV: atazanavir, AZT: zidovudine, D4T: stavudine, DRV: darunavir...

CLINICAL SCIENCE Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1–Infected Patients

Edwin Dejesus
Louis Sloan
Douglas J. Ward
K John F. Flaherty
Ramin Ebrahimi

February 2015

Objective: To evaluate a simplification strategy for HIV-1–infected patients virologically suppresse...

Summary of cohorts.

Mykola Pinkevych (125551)
Deborah Cromer (282682)
Martin Tolstrup (148124)
Andrew J. Grimm (249527)
David A. Cooper (198765)
Sharon R. Lewin (130160)
Ole S. Søgaard (148120)
Thomas A. Rasmussen (174789)
Stephen J. Kent (90625)
Anthony D. Kelleher (242189)
Miles P. Davenport (68365)

July 2015

* One subject was treated with ART early after diagnosis of unclear duration of HIV infection, th...

Shape of the concentration-prophylaxis profile.

Sulav Duwal (152805)
Laura Dickinson (5394566)
Saye Khoo (575924)
Max von Kleist (152808)

February 2019

Colored lines depict the concentration-prophylaxis profile for an average drug class-specific slope ...

Ordinary least squares regression of the natural log of total per patient costs for the first year on ART against study site and patient-specific characteristicsa.

Callie A. Scott (324456)
Hari Iyer (69841)
Deophine Lembela Bwalya (428682)
Kelly McCoy (428683)
Gesine Meyer-Rath (144675)
Crispin Moyo (428684)
Carolyn Bolton-Moore (428685)
Bruce Larson (325522)
Sydney Rosen (213204)

June 2013

3TC: lamivudine; ABC: abacavir; ART: antiretroviral therapy; AZT: zidovudine; CI: confidence inte...

Flow diagram of patients enrolled in the TrEAT TD clinical trial and paired samples that were included in the present analysis.

Tahaniyat Lalani (328713)
Michele D. Tisdale (5704316)
Jie Liu (15128)
Indrani Mitra (663794)
Cliff Philip (5704319)
Elizabeth Odundo (5704322)
Faviola Reyes (5704325)
Mark P. Simons (846690)
Jamie A. Fraser (5704328)
Emma Hutley (5704331)
Patrick Connor (5704334)
Brett E. Swierczewski (370939)
Eric Houpt (75426)
David R. Tribble (371883)
Mark S. Riddle (371884)

August 2018

Flow diagram of patients enrolled in the TrEAT TD clinical trial and paired samples that were includ...

Flow chart of participants through the clinical trial.

Huijuan Kou (276581)
Xiaoli Du (276582)
Yanling Li (269030)
Jing Xie (180526)
Zhifeng Qiu (269028)
Min Ye (171404)
Qiang Fu (129583)
Yang Han (269027)
Zhu Zhu (142480)
Taisheng Li (269024)

January 2013

ART: antiretroviral therapy; AZT: zidovudine; NVP: nevirapine; 3TC: lamivudine; D4T: stavudine; C...

CONSORT Diagram.

Kirsten Salado-Rasmussen (712677)
Zahra P. Theilgaard (712678)
Mercy G. Chiduo (712679)
Ib C. Bygbjerg (151419)
Jan Gerstoft (67009)
Margrethe Lüneborg-Nielsen (712680)
Martha Lemnge (103946)
Terese L. Katzenstein (417663)

March 2015

The flow chart indicates the number of women included from the ComTru study. The women were alloc...

Flow diagram of patient selection.

Yohei Hamada (434087)
Takeshi Nishijima (212471)
Hirokazu Komatsu (209445)
Katsuji Teruya (212494)
Hiroyuki Gatanaga (205448)
Yoshimi Kikuchi (212497)
Shinichi Oka (205454)

July 2013

ART, antiretroviral treatment; ATV, atazanavir; PIs, protease inhibitors; LPV/r, lopinavir/ritona...

Included studies and treatment groups.

Frederick J. Lee (564804)
Janaki Amin (157661)
Andrew Carr (157672)

May 2014

ABC, abacavir; AZT, zidovudine; APV, amprenavir; AZV, atazanavir; d4T, stavudine; ddI, didanosine...

Study flowchart.

Janneke H. van Dijk (277226)
Catherine G. Sutcliffe (185370)
Francis Hamangaba (277227)
Christopher Bositis (277228)
Douglas C. Watson (277229)
William J. Moss (185392)

January 2013

ART: antiretroviral treatment; ATT: anti-tuberculous treatment; EFV: efavirenz; FU: follow-up; LT...

Flow diagram of patient selection.

Takeshi Nishijima (212471)
Yohei Hamada (434087)
Koji Watanabe (205444)
Hirokazu Komatsu (209445)
Ei Kinai (212480)
Kunihisa Tsukada (212489)
Katsuji Teruya (212494)
Hiroyuki Gatanaga (205448)
Yoshimi Kikuchi (212497)
Shinichi Oka (205454)

October 2013

ART, antiretroviral therapy; ATV, atazanavir; DRV/r, ritonavir-boosted darunavir; ATV/r, ritonavi...

Drug-combination counts for therapies in EuResistTCE and HIVdbTCE.

Alejandro Pironti (738435)
Nico Pfeifer (45036)
Hauke Walter (367450)
Björn-Erik O. Jensen (3916373)
Maurizio Zazzi (146810)
Perpétua Gomes (257023)
Rolf Kaiser (238438)
Thomas Lengauer (14699)

April 2017

The frequencies of the 20 most-frequent drug combinations in EuResistTCE (a) and HIVdbTCE (b) dat...

Flowchart of the selection of study participants.

In Ah Choi (6185000)
Jeong Seok Lee (2236030)
Yeong Wook Song (219636)
Eun Young Lee (219648)

January 2019

*Methotrexate, sulfasalazine, hydroxychloroquine, leflunomide, tacrolimus, bucillamine, mizoribine, ...

Study Characteristics.

Nathan Ford (59436)
Zara Shubber (279389)
Andrew Hill (95939)
Marco Vitoria (183846)
Meg Doherty (482820)
Edward J. Mills (34548)
Andy Gray (482821)

November 2013

3TC, lamivudine; ATV/r, ritonavir-boosted atazanavir; AZT, zidovudine; ABC, abacavir; d4T, stavud...

Clinical details of HIV-1 infected patients used in this study.

Edwin Leeansyah (366399)
Jingling Zhou (332197)
Geza Paukovics (287229)
Sharon R. Lewin (130160)
Suzanne M. Crowe (220340)
Anthony Jaworowski (220337)

February 2013

13TC: lamivudine, ABC: abacavir, ATV: atazanavir, AZT: zidovudine, D4T: stavudine, DRV: darunavir...

CLINICAL SCIENCE Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1–Infected Patients

Edwin Dejesus
Louis Sloan
Douglas J. Ward
K John F. Flaherty
Ramin Ebrahimi

February 2015

Objective: To evaluate a simplification strategy for HIV-1–infected patients virologically suppresse...

Summary of cohorts.

Mykola Pinkevych (125551)
Deborah Cromer (282682)
Martin Tolstrup (148124)
Andrew J. Grimm (249527)
David A. Cooper (198765)
Sharon R. Lewin (130160)
Ole S. Søgaard (148120)
Thomas A. Rasmussen (174789)
Stephen J. Kent (90625)
Anthony D. Kelleher (242189)
Miles P. Davenport (68365)

July 2015

* One subject was treated with ART early after diagnosis of unclear duration of HIV infection, th...

Shape of the concentration-prophylaxis profile.

Sulav Duwal (152805)
Laura Dickinson (5394566)
Saye Khoo (575924)
Max von Kleist (152808)

February 2019

Colored lines depict the concentration-prophylaxis profile for an average drug class-specific slope ...

Ordinary least squares regression of the natural log of total per patient costs for the first year on ART against study site and patient-specific characteristicsa.

Callie A. Scott (324456)
Hari Iyer (69841)
Deophine Lembela Bwalya (428682)
Kelly McCoy (428683)
Gesine Meyer-Rath (144675)
Crispin Moyo (428684)
Carolyn Bolton-Moore (428685)
Bruce Larson (325522)
Sydney Rosen (213204)

June 2013

3TC: lamivudine; ABC: abacavir; ART: antiretroviral therapy; AZT: zidovudine; CI: confidence inte...

Flow diagram of patients enrolled in the TrEAT TD clinical trial and paired samples that were included in the present analysis.

Tahaniyat Lalani (328713)
Michele D. Tisdale (5704316)
Jie Liu (15128)
Indrani Mitra (663794)
Cliff Philip (5704319)
Elizabeth Odundo (5704322)
Faviola Reyes (5704325)
Mark P. Simons (846690)
Jamie A. Fraser (5704328)
Emma Hutley (5704331)
Patrick Connor (5704334)
Brett E. Swierczewski (370939)
Eric Houpt (75426)
David R. Tribble (371883)
Mark S. Riddle (371884)

August 2018

Flow diagram of patients enrolled in the TrEAT TD clinical trial and paired samples that were includ...

Flow chart of study design. Rx = treatment; AZT = zidovdine and lamivudine; TDF = tenofovir and emtricitabine; ABC = abacavir and lamivudine.

Abstract

Extracted data

Flow chart of study design. Rx = treatment; AZT = zidovdine and lamivudine; TDF = tenofovir and emtricitabine; ABC = abacavir and lamivudine.

Abstract

Extracted data

Topics

Related items

Topics

Related items